Related Experiment Videos
New retinoids for dermatologic diseases. Uses and toxicity
Abstract:
Systemic administration of retinoids is frequently associated with mucocutaneous side effects, liver toxicity, and abnormalities of the serum lipid profile. Currently, the main factors limiting more common use of retinoids are their teratogenicity and chronic bone toxicity. Treatment with retinoids requires appropriate selection of patients, careful periodic monitoring of the clinical response, and appropriate laboratory tests. Careful therapeutic management is necessary in order to prevent or minimize side effects.
Insights
Systemic retinoids can cause side effects like skin issues, liver toxicity, and lipid abnormalities. Careful patient selection and monitoring are crucial to manage these risks during retinoid therapy.
Area of Science:
- Dermatology and Pharmacology
- Toxicology
Background:
- Systemic retinoid administration is linked to various adverse effects.
- Key limitations include teratogenicity and chronic bone toxicity.
- Managing these requires careful patient selection and monitoring.
Purpose of the Study:
- To summarize the known side effects of systemic retinoids.
- To highlight the importance of therapeutic management in mitigating risks.
Main Methods:
- Literature review of retinoid-associated toxicities.
- Analysis of factors limiting retinoid use.
Main Results:
- Common side effects include mucocutaneous issues, hepatotoxicity, and dyslipidemia.
- Teratogenicity and bone toxicity are significant concerns.
- Effective management involves patient selection and laboratory monitoring.
Conclusions:
- Retinoid therapy necessitates vigilant clinical and laboratory monitoring.
- Careful therapeutic management is essential to minimize adverse events and ensure patient safety.